The more severe PGE2-mediated monocyte dysfunction in patients hospitalised with AD/ACLF compared with OPDs could partly explain the lack of effect of albumin infusions in the prevention of infection in the ATTIRE trial, compared with the reduction in infections in the ANSWER trial.25 Here, ALB is linked to Alzheimer disease.